EP Patent

EP4119167A4 — Single-stranded nucleic acid molecule for inducing 1-frame shift and assembly

Assigned to Biocomber Co Ltd · Expires 2025-08-06 · 1y expired

What this patent protects

Patent listed against Viltepso.

Drugs covered by this patent

Viltepso (VILTOLARSEN) · Nippon Shinyaku

Patent Metadata

Patent number: EP4119167A4
Jurisdiction: EP
Classification: —
Expires: 2025-08-06
Drug substance claim: No
Drug product claim: No
Assignee: Biocomber Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.